As of 2025-04-19, the Relative Valuation of Zentalis Pharmaceuticals Inc (ZNTL) is (77.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Zentalis Pharmaceuticals Inc based on Relative Valuation is -6097.3%.
The range of the Relative Valuation is (63.51) - (78.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.5x - 41.9x | 36.5x |
| Forward P/E multiples | 23.5x - 33.8x | 30.5x |
| Fair Price | (63.51) - (78.01) | (77.37) |
| Upside | -5023.2% - -6147.4% | -6097.3% |
| Date | P/E |
| 2025-04-17 | -0.56 |
| 2025-04-16 | -0.55 |
| 2025-04-15 | -0.55 |
| 2025-04-14 | -0.53 |
| 2025-04-11 | -0.53 |
| 2025-04-10 | -0.49 |
| 2025-04-09 | -0.51 |
| 2025-04-08 | -0.45 |
| 2025-04-07 | -0.50 |
| 2025-04-04 | -0.51 |
| 2025-04-03 | -0.56 |
| 2025-04-02 | -0.59 |
| 2025-04-01 | -0.60 |
| 2025-03-31 | -0.69 |
| 2025-03-28 | -0.78 |
| 2025-03-27 | -0.78 |
| 2025-03-26 | -0.76 |
| 2025-03-25 | -0.81 |
| 2025-03-24 | -0.86 |
| 2025-03-21 | -0.83 |
| 2025-03-20 | -0.79 |
| 2025-03-19 | -0.78 |
| 2025-03-18 | -0.77 |
| 2025-03-17 | -0.82 |
| 2025-03-14 | -0.77 |
| 2025-03-13 | -0.78 |
| 2025-03-12 | -0.84 |
| 2025-03-11 | -0.80 |
| 2025-03-10 | -0.78 |
| 2025-03-07 | -0.79 |
| 2025-03-06 | -0.84 |
| 2025-03-05 | -0.84 |
| 2025-03-04 | -0.81 |
| 2025-03-03 | -0.83 |
| 2025-02-28 | -0.90 |
| 2025-02-27 | -0.87 |
| 2025-02-26 | -0.93 |
| 2025-02-25 | -0.92 |
| 2025-02-24 | -0.96 |
| 2025-02-21 | -1.00 |
| 2025-02-20 | -1.07 |
| 2025-02-19 | -1.10 |
| 2025-02-18 | -1.07 |
| 2025-02-14 | -1.05 |
| 2025-02-13 | -1.05 |
| 2025-02-12 | -0.94 |
| 2025-02-11 | -0.90 |
| 2025-02-10 | -0.89 |
| 2025-02-07 | -0.83 |
| 2025-02-06 | -0.94 |